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Mucormycosis is a rare disease with a high mortality rate. Common sites of 
mucormycosis include cerebral, pulmonary, gastrointestinal and dissemi-
nated lesions. We present the case of a 58-year-old woman with chronic 
alcoholism who was admitted to our intensive care unit with the initial 
presentation of abdominal pain. Colonic perforation was diagnosed upon 
surgical intervention. The patient soon developed upper gastrointestinal 
bleeding, and two masses at the body and antrum of the stomach were 
found on endoscopy. Pathological examination results showed invasive 
mucormycosis. The association of alcoholism and mucormycosis is empha-
sized in this case. [Tzu Chi Med J 2007;19(3):169–172]
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1. Introduction
Mucormycosis is a common name given to several 
different diseases caused by fungi of the order Muco-
rales [1]. It is commonly involved in rhinocerebral 
infections in patients with diabetes or malignancy, 
as well as pulmonary and disseminated manifesta-
tions in patients with hematological malignancies. 
The gastrointestinal form of the disease is primarily 
found in patients suffering from extreme malnutri-
tion [2]. Here, we present a rare case of gastric muco r-
mycosis in a patient with schizophrenia and chronic 
alcoholism.
2. Case report
A 58-year-old woman with schizophrenia was admit-
ted to the emergency department complaining of 
persistent severe abdominal pain and cold sweats 
for 1 hour. Her medical history was significant for 
chronic alcoholism, hypertension with irregular con-
trol of medication, impaired glucose tolerance with-
out oral medication, rectal polyp status post local 
excision 10 months prior to this admission, and 
chronic constipation for 4 years requiring manual 
discompaction.
Upon arrival at the emergency department, the 
patient’s blood pressure was 206/112 mmHg. Abdo-
minal examination revealed diffuse tenderness with 
hypoactive bowel sounds. Furthermore, laboratory 
study results showed hyponatremia (Na, 123 mmol/L) 
and hypokalemia (K, 2.7 mmol/L). An upright chest 
X-ray showed subphrenic free air, which suggested 
bowel perforation.
The surgeon performed an emergency laparotomy 
and found multiple perforations in the ascending colon 
with feces spreading within the entire abdominal 
cavity. Unsurprisingly, hard stool was found in the 
sigmoid colon which caused partial obstruction. 
The patient then underwent a right hemicolectomy. 
She was transferred to the intensive care unit and 
her condition stabilized.
However, on the third postoperative day, the 
patient developed acute upper gastrointestinal bleed-
ing with coffee-ground aspirate from the nasogas tric 
tube. Upper endoscopy revealed one mass measur-
ing 4 cm at the angle of the stomach. Additionally, a 
separate 5-cm mass was seen in the posterior wall of 
the body. Some A2 ulcers were seen on the surface 
of the masses (Figs. 1 and 2). Histopathological eval-
uation demonstrated numerous broad, non sep tate 
hyphae with right-angle branched fungi with hema-
toxylin and eosin as well as silver stains in the exu-
dates within the ulcer, which suggested mucor myces 
(Figs. 3 and 4). She received amp ho tericin B 0.5 g/kg/
day for 28 days, which was discontinued when follow-
up endoscopy showed complete resolution of the 
gas tric masses (Fig. 5). The patient’s subsequent 
hospital course was uneventful and there was no evi-
dence of recurrent ulcers or bleeding.
3. Discussion
Zygomycoses are infections caused by fungi of the 
class Zygomycetes, which is composed of the orders 
Mucorales and Entomophthorals [3]. The term mucor-
mycosis is familiar and used by most clinicians as it 
is widely used in reports in the medical literature. In 
addition, it is used as an indexing term within medical 
databases.
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Fig. 1 — Endoscopy reveals a 4-cm mass in the gastric 
antrum. Some A2 ulcers can be seen on the surface of 
the masses.
Fig. 2 — Endoscopy reveals a 5-cm mass on the posterior 
wall of the gastric body.
Fig. 3 — Photomicrograph shows gastric necrotic mucosal 
surface with numerous hyphae (hematoxylin & eosin; 
original magnification, 400´).
Fig. 4 — Photomicrograph shows numerous broad diameter, 
nonseptate hyphae with branches occurring at right angles 
(periodic acid-Schiff; original magnification, 400´).
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Mucormycosis usually involves rhinocerebral infec-
tions which account for more than half of the cases 
[1]. Gastrointestinal tract infections are rare, and 
affect only 7% of all zygomycosis cases [4]. In non-
transplant patients, the stomach is the site most fre-
quently involved (67%), followed by the colon (21%), 
small intestine (4%), and esophagus (2%) [5]. Gastric 
mucormycosis is primarily found in patients with dia-
betes mellitus, solid organ transplantation, cortico-
steroid use and malnutrition. Cases associated with 
acquired immunodeficiency syndrome and iatrogenic 
outbreaks and those that followed use of wooden 
tongue depressors have been reported [6,7].
After reviewing the present case, alcoholism 
seems to be one of the risk factors of gastric mucor-
mycosis which is seldom described in published 
reports in the medical literature. We propose the 
following explanation for the pathogenic basis of 
alcoholism in gastric mucomycosis. Firstly, it is known 
that neutrophils are the prominent components of 
the host immune system that respond to the Mucor-
ales [1]. Secondly, oxidative metabolites that are 
generated by phagocyte respiratory burst have been 
shown to be fungicidal to Rhizopus oryzae hyphae 
[8]. Thirdly, patients with acute or chronic alcohol 
abuse have impaired cellular immunity, which is 
particularly notable with regards to antigen-specific 
immune response. It thereby, unavoidably, increases 
the host’s susceptibility to infections [9].
Two cases of gastric mucormycosis in patients with 
alcoholism have been reported [10,11]. Both cases 
described patients with abdominal pain similar to our 
patient. One patient had melena and hematemesis 
and the other appeared toxic with fever and vomit-
ing. Upper endoscopy revealed ulcerated lesions with 
raised edges and necrotic base contained thick-dirty 
necrotic debris and hemorrhage clots. Therefore, 
we suggest that alcoholism might be one of the risk 
factors for gastric mucormycosis. Also, we would 
point out that ingesting fungal spores and germina-
tion by patients with alcoholism can be harmful, as 
ethanol may disrupt activation of macrophages and 
dendritic cells, which play crucial roles in immunity 
for eliminating fungal spores.
The initial manifestations of gastrointestinal mucor-
my cosis are abdominal pain and distention associated 
with nausea and vomiting [1]. Fever and hemato-
chezia may also be found. The diagnosis of gastroin-
testinal mucormycosis is made in accor dance with 
endoscopic biopsy results of the lesions that show the 
characteristics of broad hyphae, irregular branched 
and rare septations. The hyphae of the fungi in this 
case were differentiated from those of Aspergillus, 
because hyphae of Aspergillus are narrower with 
regular branching and many septations. Routine histo-
logical stain with hematoxylin and eosin or with spe-
cial stains such as Grocott’s methenamine–silver and 
periodic acid-Schiff are adequate to identify fungal 
hyphae. On the other hand, since Mucor species are 
pot entially angioinvasive, infarction and necrosis of 
host tissues are seen as the hallmarks of invasive 
disease.
Because of its rapidly progressive and fatal clinical 
course, the crucial medical intervention for mucormy-
cosis includes correcting underlying diseases, remov-
ing necrotic tissue by surgery and using antifungal 
agents promptly. Meanwhile, amphotericin B deoxycho-
late and its lipid derivatives remain as the stan dard 
therapy for mucormycosis. The recommended dose of 
amphotericin B deoxycholate is 1 to 1.5 mg/kg/day. As 
to other newer antifungal agents, such as voriconazole 
and caspofungin, they are not effective against mucor-
mycosis. Furthermore, a novel extended-spectrum 
investigational triazole named posaconazole has a 
potential role in the treatment of zygomycosis that is 
refractory to the standard therapy. In a clinical trial 
of 91 patients with either proven (n = 69) or probable 
(n = 22) infections with zygomycosis who failed or 
could not tolerate stan dard therapy, posaconazole 
achieved either complete or partial response in 60% 
of patients, while 21% were stabilized [12].
Previously researchers have reported that the mor-
tality rate of those with gastric mucormycosis ap -
pro aches 98% [13]. Hence, prompt diagnosis, reversal 
of predisposing condition, aggressive surgical debride-
ment and early use of amphotericin B are the corner-
stones of therapy for this fatal disease. Astute clinicians 
should also recognize alcoholism as a risk factor for 
gastric mucormycosis.
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